{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-160789","form_type":"8-K","ticker":"ACRV","cik":"0001781174","company_name":"Acrivon Therapeutics, Inc.","filed_at":"2023-06-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.531972+00:00","generated_at":"2026-06-14T07:29:13.737609+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Acrivon Therapeutics amends EVP Kristina Masson's employment agreement with $382,200 base salary","bullets":["Amended employment agreement with Kristina M. Masson, EVP of Business Operations and board member, effective June 1, 2023.","Base salary set at $382,200; target annual bonus up to 40% of salary.","Separate Swedish employment agreement for role as President/CEO of Acrivon AB with base salary $163,800.","Severance: if terminated without cause or for good reason, 9 months base salary plus pro-rata bonus; enhanced terms after change of control."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-160789","json":"https://secwatch.observer/filing/0001193125-23-160789.json","markdown":"https://secwatch.observer/filing/0001193125-23-160789.md","text":"https://secwatch.observer/filing/0001193125-23-160789.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1781174/000119312523160789/0001193125-23-160789-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1781174/000119312523160789/d508323d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T07:29:13.737609+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}